To date, efficacy of therapeutic response to immunotherapy is assessed mainly by estimating the degree of tumor necrosis and fibrosis.39 Indicators of CD8+ T cell infiltration have been associated with patient survival and treatment outcomes, but direct evidence of effective immune cell-tumor cell interaction is still missing. Here, CD8A is linked to neoplasm.